Axos Financial, Inc. (NYSE:AX – Free Report) – Analysts at Wedbush dropped their Q1 2026 earnings per share (EPS) estimates for Axos Financial in a research note issued to investors on Thursday, October 31st. Wedbush analyst D. Chiaverini now expects that the company will post earnings of $1.75 per share for the quarter, down from their previous forecast of $2.06. Wedbush currently has a “Neutral” rating and a $75.00 target price on the stock. The consensus estimate for Axos Financial’s current full-year earnings is $6.97 per share. Wedbush also issued estimates for Axos Financial’s Q2 2026 earnings at $1.78 EPS and FY2026 earnings at $7.25 EPS.
Axos Financial (NYSE:AX – Get Free Report) last announced its quarterly earnings data on Wednesday, October 30th. The company reported $1.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.80 by $0.16. The firm had revenue of $512.87 million during the quarter, compared to the consensus estimate of $299.59 million. Axos Financial had a return on equity of 18.99% and a net margin of 24.07%. During the same quarter in the prior year, the company earned $1.41 EPS.
Get Our Latest Research Report on Axos Financial
Axos Financial Trading Down 1.0 %
Shares of AX opened at $65.21 on Monday. Axos Financial has a fifty-two week low of $32.05 and a fifty-two week high of $79.15. The business has a 50-day moving average of $64.88 and a 200 day moving average of $61.66. The firm has a market cap of $3.72 billion, a P/E ratio of 7.96 and a beta of 1.38. The company has a debt-to-equity ratio of 0.17, a quick ratio of 1.08 and a current ratio of 1.08.
Insiders Place Their Bets
In related news, EVP Andrew J. Micheletti sold 5,197 shares of the stock in a transaction dated Monday, September 9th. The stock was sold at an average price of $63.13, for a total transaction of $328,086.61. Following the completion of the sale, the executive vice president now owns 424,149 shares in the company, valued at approximately $26,776,526.37. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 5.07% of the company’s stock.
Institutional Investors Weigh In On Axos Financial
Hedge funds have recently bought and sold shares of the business. Venturi Wealth Management LLC bought a new stake in shares of Axos Financial during the third quarter worth $189,000. Ashton Thomas Securities LLC purchased a new position in shares of Axos Financial during the third quarter valued at $41,000. Crossmark Global Holdings Inc. lifted its stake in Axos Financial by 4.4% in the third quarter. Crossmark Global Holdings Inc. now owns 3,836 shares of the company’s stock worth $241,000 after acquiring an additional 162 shares during the period. Summit Global Investments raised its holdings in shares of Axos Financial by 2.5% in the 3rd quarter. Summit Global Investments now owns 19,681 shares of the company’s stock valued at $1,238,000 after purchasing an additional 482 shares in the last quarter. Finally, Principal Financial Group Inc. raised its stake in Axos Financial by 27.9% in the third quarter. Principal Financial Group Inc. now owns 320,717 shares of the company’s stock worth $20,167,000 after buying an additional 70,017 shares in the last quarter. Hedge funds and other institutional investors own 83.79% of the company’s stock.
About Axos Financial
Axos Financial, Inc, together with its subsidiaries, provides consumer and business banking products in the United States. It operates through two segments, Banking Business and Securities Business. The company offers deposits products, including consumer and business checking, demand, savings, time deposit, money market, zero balance, and insured cash sweep accounts.
Featured Stories
- Five stocks we like better than Axos Financial
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- Intel: Is Now the Time to Be Brave?Â
- What Are Some of the Best Large-Cap Stocks to Buy?
- Carnival or Royal Caribbean—Which Cruise Stock Has More Upside?
- How to Capture the Benefits of Dividend Increases
- Summit Therapeutics: Is Their Lung Cancer Drug a Game Changer?
Receive News & Ratings for Axos Financial Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axos Financial and related companies with MarketBeat.com's FREE daily email newsletter.